Off-Label use of intravenous immunoglobulin for autoimmune or inflammatory conditions: a review of clinical effectiveness
This review aims to evaluate the clinical effectiveness of intravenous immunoglobulin (IVIG) in autoimmune or inflammatory conditions for which there is no Health Canada approval for the use of IVIG.
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
April 6, 2018, 2018
|
Edition: | Version: 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This review aims to evaluate the clinical effectiveness of intravenous immunoglobulin (IVIG) in autoimmune or inflammatory conditions for which there is no Health Canada approval for the use of IVIG. |
---|---|
Physical Description: | 1 PDF file (40 pages) illustration |